Global Health Limited
Global Health Limited operates in Hospital, part of the Healthcare sector. It booked ₹1,469 cr of revenue in its latest quarter (Q2 FY27) and kept 14.9% of sales as profit. It is the 6th largest of 9 Hospital companies we track, by market value.
“is to deliver world-class, patient-centric, integrated and a sustainable, large-format healthcare platform.”
Healthier than 65% of companies in Healthcare, on all six measures of filed financials. Each measure is ranked against the 80–153 companies that reported it.
Measures financial condition, not whether to buy. Learn what this score means · How this is calculated
- RSI (14)
- 53
At close. Not part of the score.
How much profit it earns on the money it employs
How much it owes, and whether earnings cover the interest
Whether reported profit actually arrives as cash
Whether sales and profit have grown, and how steadily
What today's price implies, against our models or its peers
How much of the promoters' stake is pledged, and how much they hold
What if I invest in MEDANTA?
Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.
The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-11-04.
An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.
| Revenue from Operations | ₹1,469 cr |
| Other Income | ₹24 cr |
| Total Income | ₹1,493 cr |
| Cost of Materials | ₹279 cr |
| Purchases of Stock-in-Trade | ₹46 cr |
| Inventory Change (±) | ₹-3 cr |
| Employee Benefit Expense | ₹335 cr |
| Finance Costs | ₹28 cr |
| Depreciation & Amortisation | ₹71 cr |
| Other Expenses | ₹443 cr |
| Total Expenses | ₹1,198 cr |
| Profit before Tax | ₹295 cr |
| Tax Expense | ₹76 cr |
| Net Profit | ₹219 cr |
| Net margin on total income | 14.7% |
| Metric | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|
| Revenue | 1,159 cr | 1,304 cr | 1,469 cr |
| Total income | 1,196 cr | 1,326 cr | 1,493 cr |
| Expenses | 1,009 cr | 1,113 cr | 1,198 cr |
| Profit before tax | 187 cr | 213 cr | 295 cr |
| Tax | 46 cr | 56 cr | 76 cr |
| Net profit (owners' share) | 144 cr | 159 cr | 219 cr |
| Net margin (owners' share, on revenue) | 12.4% | 12.2% | 14.9% |
| EPS (₹) | 5.36 | 5.91 | 8.21 |
| Company | Price | Market cap | P/E | ROE | Net margin | 1-yr return |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹8,440 | ₹1.21 L cr | 52.2 | 24.5% | 8.2% | — |
| Max Healthcare Institute Limited | ₹896 | ₹87,160 cr | 52.6 | 14.6% | 16.2% | — |
| Manipal Health Enterprises Limited | ₹642 | ₹75,740 cr | 81.9 | — | 7.5% | — |
| Fortis Healthcare Limited | ₹786 | ₹59,306 cr | 55.6 | 10.8% | 10.5% | — |
| Narayana Hrudayalaya Ltd. | ₹1,871 | ₹38,228 cr | 31.6 | 24.1% | 10.6% | — |
| Global Health Limitedthis company | ₹1,326 | ₹35,621 cr | 40.4 | 20.3% | 14.9% | — |
| Aster DM Quality Care Limited | ₹681 | ₹35,303 cr | 549.5 | 1.4% | 1.2% | — |
| Krishna Institute of Medical Sciences Limited | ₹731 | ₹30,681 cr | 175.6 | 7.4% | 3.5% | — |
| Dr. Agarwal's Health Care Limited | ₹513 | ₹16,256 cr | 89.7 | 8.9% | 7.4% | — |
| Action | Detail | Ex-date |
|---|---|---|
| Dividend | ₹0.5 / share | 14 Aug 2026 |
| Dividend | ₹0.5 / share | 22 Aug 2025 |
A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.
Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.
Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.
The company also transacted with 17 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.
Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.